Galanin has been shown to be an important neuropeptide associated with the preovulatory surge of gonadotropins. Since the preovulatory surge of gonadotropins is induced by the action of estrogens and progesterone, the present study examined the effect of estrogens and progesterone on hypothalamic and pituitary galanin mRNA levels. Galanin mRNA was present as the 900-base pair message in the hypothalamus and the pituitary. In the 27-day-old ovariectomized immature rat, treatment with 2 µg of estradiol for 2 days did not bring about any changes in hypothalamic galanin mRNA levels. In adult rats, ovariectomy also did not bring about any changes in hypothalamic galanin mRNA levels. However, 14 days of estradiol replacement increased hypothalamic galanin mRNA levels. Progesterone treatment in the estrogen-primed ovariectomized immature rat resulted in a significant increase in hypothalamic galanin mRNA levels at 12:00 and 14:00 h. This increase occurred at the time of the initiation of the progesterone-induced LH and FSH surges. Estrogen treatment enhanced pituitary galanin mRNA levels which were further increased by progesterone treatment at 12:00 h, the time of the initiation of the gonadotropin surge by progesterone. In the PMSG-primed immature rat, pituitary galanin mRNA levels were increased due to ovarian estrogen and progesterone secretion as a result of PMSG treatment. Pituitary galanin mRNA levels were decreased by the anti-progestin RU486 at 12:00 and 20:00 h, times that coincided with a decrease in serum LH by RU486 as compared to the PMSG-treated controls. Thus, galanin is an important neuropeptide that acts at the level of the hypothalamus and the pituitary in modulating the gonadotropin surge and is regulated by progesterone in both tissues.

Keywords:
Galanin mRNA levels, Hypothalamus, Pituitary, Progesterone, LH surge
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.